Table 1.
Study | Modality/Method of Analysis | Resting-State | N(SCZ/HC) | Foci | Reported Contrasts | Patient Details | Drug Status |
Andreasen et al62 | PET | No information | 17/17 | 13 | HC > SCZ | First-episode SCZ | Unmedicated |
12 | SCZ > HC | ||||||
Camchong et a63 | fMRI/ICA | 6 min, eyes closed | 29/29 | 1 | HC > SCZ | Chronic SCZ | Medicated |
Hoptman et al19 | fMRI/ALFF | 6 min, eyes closed | 29/26 | 15 | HC > SCZ | Chronic SCZ | Medicated |
8 | SCZ > HC | ||||||
Huang et al20 | fMRI/ALFF | 6.7 min | 66/66 | 1 | HC > SCZ | First-episode SCZ | Unmedicated |
2 | SCZ > HC | ||||||
Liu et al21 | fMRI/ReHo | 6 min, eyes closed | 18/18 | 28 | HC > SCZ | First-episode SCZ | > 6-h medication washout |
Malaspina et al22 | SPECT | 20 min, eyes open | 16/9 | 11 | HC > SCZ | Chronic SCZ | Mixed |
3 | SCZ > HC | ||||||
Mannell et al23 | fMRI/ICA | Several blocks of 3-min rest in-between task, eyes open | 16/16 | 7 | HC > SCZ | Chronic SCZ | Medicated |
Öngür et al24 | fMRI/ICA | 10 min, eyes open | 14/15 | 1 | HC > SCZ | Chronic SCZ with acute psychosis | Medicated |
9 | SCZ > HC | ||||||
Park et al25 | FDG PET | 15 min, eyes closed | 29/21 | 6 | HC > SCZ | Chronic SCZ | Medicated |
8 | SCZ > HC | ||||||
Salvador et al26 | fMRI/whole brain but subdivided into ROIs | 8.9 min, eyes open | 40/40 | 1 | SCZ > HC | Chronic SCZ | Medicated |
Scheef et al27 | ASL | 6 min, eyes closed | 11/25 | 8 | HC > SCZ | 8 first-episode SCZ, 3 chronic SCZ | Unmedicated |
6 | SCZ > HC |
Note: SCZ, schizophrenia; HC, healthy controls; fMRI, functional magnetic resonance imaging; PET, positron emission tomography; ASL, arterial spin labeling; SPECT, single photon emission computed tomography; ICA, independent component analysis; ALFF, amplitude of low frequency fluctuations; ReHo, regional homogeneity; ROIs, regions of interest.